Oral DLBS1033 for diabetic nerve pain
Part of Brain & nervous system, Genetic & congenital, Hormones & metabolism clinical trials.
This study tests whether a daily oral supplement called DLBS1033 can help relieve nerve pain and other symptoms of diabetic polyneuropathy. It may be a good option if you have stable blood sugar and no other major health issues.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 60 years old.
- You have been diagnosed with diabetic polyneuropathy by a neurologist.
- Your HbA1c (average blood sugar) is between 7% and 10% in the last month.
- You are not pregnant, breastfeeding, or planning pregnancy.
- You do not have other serious health problems like kidney, liver, or severe heart disease.
- You have not been a heavy drinker for many years and are not a heavy smoker.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a combination of alpha lipoic acid (a natural antioxidant) and vitamin B supplements can help relieve nerve pain, numbness, or tingling caused by diabetes. It is for people with type 2 diabetes who have diabetic nerve damage.
This trial tests if adding DLBS1033 to standard treatment can help people with diabetic neuropathy, a nerve condition causing pain or numbness from diabetes. It aims to see if it improves nerve symptoms and quality of life.
This study tests a new drug (HL-1186) for diabetic nerve pain. It aims to see if it reduces pain safely in people with type 1 or type 2 diabetes who have had nerve pain for at least 6 months.
This trial tests an investigational drug for people with pain caused by nerve damage from diabetes (diabetic peripheral neuropathy). It may help reduce pain in your lower legs if other treatments haven't worked well.
This trial tests if Levagen+ (a supplement) can reduce nerve pain caused by diabetes. It is for people with type 1 or type 2 diabetes who have significant nerve pain in their feet or legs.
This Phase 3 study tests Praga formulation to see if it safely reduces nerve pain caused by diabetes. You may qualify if you’re an adult with painful diabetic neuropathy and have certain symptom and pain scores on questionnaires.
Hear when a new Diabetic Polyneuropathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.